Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer
by on Thursday, April 26th, 2012 | No Comments
Conditions: brca1 Mutation Carrier; brca2 Mutation Carrier; Pancreatic Cancer
Interventions: Drug: cisplatin; Drug: gemcitabine hydrochloride; Drug: veliparib
Sponsors: National Cancer Institute (NCI); Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Not yet recruiting – verified April 2012
Continue reading here: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer